What is the current Global Empty Capsules Market size?

The Global Empty Capsules Market is projected to register a CAGR of 7.40% during the forecast period (2024-2029) Read More

Who are the key players in Global Empty Capsules Market?

ACG Worldwide, Capscanada Corporation, Medi-Caps Ltd, Bright Pharma Caps Inc and Lonza Group(Capsugel) are the major companies operating in the Global Empty Capsules Market. Read More

Which is the fastest growing region in Global Empty Capsules Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Empty Capsules Market?

In 2024, the North America accounts for the largest market share in Global Empty Capsules Market. Read More

What years does this Global Empty Capsules Market cover?

The report covers the Global Empty Capsules Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Empty Capsules Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Empty Capsules Market Share

Statistics for the 2023 & 2024 Global Empty Capsules market share, created by Mordor Intelligence™ Industry Reports. Global Empty Capsules share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Empty Capsules Industry

Global key players are manufacturing the majority of empty capsules. Market leaders with more funds for research and a better distribution system have established their positions in the market. The empty capsules market is highly consolidated and consists of a few major players, including ACG Worldwide, Medi-Caps Ltd, LonzaGroup (Capsugel), Capscanada Corporation, and Bright Pharma Caps Inc. Moreover, Asia-Pacific is witnessing the emergence of a few small- and medium-sized players due to the rising awareness of empty capsules. Additionally, key players are involved in strategic alliances and product launches to secure their positions in the competitive market. For instance, in October 2020, Lonza invested CHF 85 million in its Capsules and Health Ingredients (CHI) division to expand its capsule manufacturing capacity by 30 billion capsules annually.